Skip to main content

Day: June 23, 2025

Alpha Modus (NASDAQ: AMOD) CEO Doubles Down with $3M Commitment Amid Execution Milestones and Imminent Revenue Surge

CORNELIUS, N.C., June 23, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (NASDAQ: AMOD), a retail AI and data monetization company, today announced a major personal capital commitment from its CEO William Alessi to further support the company’s rapid growth and operational plans for the remainder of 2025. In a strong display of confidence, Mr. Alessi and his affiliated family trusts have recently completed the exchange of a substantial block of preferred shares into common stock, aligning long-term interests with shareholders. Now, he has personally committed up to $3 million in simple debt financing to ensure Alpha Modus remains well-capitalized and strategically focused through year-end while rejecting all third-party derivative financing offerings. “This is not just a vote of confidence,” said William Alessi, CEO of Alpha...

Continue reading

Sienna Senior Living Expands in the Greater Toronto Area

MARKHAM, Ontario, June 23, 2025 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced today that it has entered into a purchase agreement to acquire Credit River Retirement Residence, a 133-suite retirement residence consisting of 84 independent living (IL), 25 assisted living (AL), and 24 memory care (MC) units in Streetsville, Ontario (“Acquisition”), located within the Greater Toronto Area (“GTA”). Built in 2016, the six-storey Class A property offers attractive amenities, including excellent health & fitness facilities, a movie theatre, multiple dining rooms and an outdoor terrace. With a current occupancy rate of 90%, we expect to achieve stabilized occupancy of 95% in this primary market within the first year of operations after closing of the transaction. The gross purchase price...

Continue reading

Preferred Bank Announces Approval of Stock Repurchase and Cash Dividend

LOS ANGELES, June 23, 2025 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the largest independent commercial banks in California, today reported that the Board of Directors has received regulatory approval to implement its recently announced $125 million stock repurchase plan which was approved by shareholders in May. Preferred Bank is not a Securities & Exchange Commission (“SEC”) registrant, therefore the Bank requires regulatory approval prior to repurchasing its own common stock. The Board of Directors has approved the first tranche of repurchases which will consist of $50 million in buybacks. The stock purchases will be made from time to time in the open market. In addition, the Board of Directors has declared a quarterly cash dividend to $0.75 per share, payable on July 22, 2025 to holders of record on July...

Continue reading

Finanskalender 2025 og 2026

BRØNDBYERNES I.F. FODBOLD A/SCVR-nr. 83 93 34 10 Brøndby, den 23. juni 2025 SELSKABSMEDDELELSE NR. 7/2025 Brøndbyernes IF Fodbold A/S – Finanskalender 2025 og 2026 Brøndbyernes IF Fodbold A/S har planlagt følgende datoer for meddelelser og ordinære generalforsamlinger i resten af 2025 og for 2026. 25. september 2025:        Årsrapport 2024/25 for perioden 1. juli 2024 – 30. juni 2025 21. oktober 2025:        Ordinær generalforsamling 5. marts 2026:                Delårsrapport 1. halvår 2025 for perioden 1. juli 2025 – 31. december 2025 24. september 2026:        Årsrapport 2025/26 for perioden 1. juli 2025 – 30. juni 2026 20. oktober 2026:        Ordinær generalforsamling Brøndby IF Bestyrelsen InformationYderligere information om denne meddelelse kan fås hos administrerende direktør Ole Palmå på telefon 43 63 08 10.Attachment...

Continue reading

Worksport Reports Consecutive Months of Record-Breaking Revenues, Gross Margin Improves by 25%

Company Reports All-Time-High Revenue in May 2025 (Following Record April 2025 Sales) as Gross Margins Rise 25% from Q1 2025 Levels; Growth Momentum Expected to Continue West Seneca, New York, June 23, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S. based manufacturer and innovator of hybrid and clean energy solutions for the light truck, overlanding, and global consumer goods sectors, today announced that May 2025 sales reached $1.28 million, marking the Company’s second consecutive month of record-breaking revenue (non-audited). Gross Margins continue to improve notably, as Worksport’s Made-in-USA cover line continues to gain significant traction. Worksport’s April and May 2025 revenues alone have surpassed total Q1 2025 revenue, signaling strong momentum entering the second half of...

Continue reading

ECD Automotive Design Secures $500M Equity Facility to Fund a Bitcoin Treasury

$500M facility earmarked for the strategic accumulation of Bitcoin to serve as the Company’s primary reserve asset and for the funding of growth and general corporate purposes. The Company will grow its digital asset footprint beyond the recent BitPay relationship to unlock the crypto-native customer demographic. First 21 customers to purchase a vehicle with Bitcoin to receive $21,000 upgrade credit.KISSIMMEE, Fla. , June 23, 2025 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (NASDAQ: ECDA), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs and Toyota FJs is thrilled to announce the signing of a $500M equity facility with ECDA Bitcoin Treasury LLC (the “Facility”). The proceeds of this strategic financing...

Continue reading

Anthony Pompliano Strikes $1 Billion Merger to Create ProCap Financial; Raises Over $750M in Largest Initial Fundraise in History for Public Bitcoin Treasury Company

ProCap Financial to strategically acquire bitcoin and generate revenue and profits from its bitcoin holdings Equity investors have immediate exposure to bitcoin based on structure of financing transactions Columbus Circle Capital Corp. I (NASDAQ: CCCM) to take ProCap Financial publicNew York, NY, June 23, 2025 (GLOBE NEWSWIRE) — American investor and entrepreneur Anthony Pompliano today announced that ProCap BTC, LLC, a bitcoin-native financial services firm, has entered into a definitive agreement for a business combination with Columbus Circle Capital Corp. I (NASDAQ: CCCM), a SPAC sponsored by a controlled subsidiary of Cohen & Company, Inc. At the closing of the proposed business combination, the combined company will operate as ProCap Financial, Inc., with up to $1 billion in bitcoin on its balance sheet. Entities...

Continue reading

Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update

Held Type C meeting with FDA on Planned New Drug Application (NDA) Submission, Including Clinical, Non-clinical, and Chemistry, Manufacturing, and Control (CMC) Requirements NDA On Track for Submission to FDA in First Half of Calendar 2025 NDA to be Supported by Data from Phase 3 STRIVE-ON Safety Trial, which Met Primary Endpoint and Provided Evidence of Clinical Benefit Compared to Orally Administered Nimodipine Secured Private Placement Financing of $15 Million in Upfront Gross Proceeds with the Potential to Receive up to an Additional $15 Million in Potential Warrant Exercise Proceeds for an Aggregate of Up to Approximately $30 Million in Potential Total Gross Proceeds PRINCETON, N.J., June 23, 2025 (GLOBE NEWSWIRE) — Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company...

Continue reading

Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger

A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) — Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc. (“Impact BioMedical”) (NYSE American: IBO), a Texas based biopharmaceuticals developer listed on the New York Stock Exchange American (“Impact BioMedical”, together with Dr Ashleys, the “Parties”), are pleased to announce the execution of a merger and share exchange agreement (the “Merger Agreement”) on June 21, 2025 to enter into a strategic merger transaction (the “Transaction”). Upon closing of the Transaction, Dr. Ashleys will acquire Impact BioMedical through a reverse merger that will result in a newly formed combined entity (the “PubCo”) traded on the NYSE American under...

Continue reading

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

Vancouver, Canada, June 23, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the addition of Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel, as an additional clinical site for its ongoing Phase I/IIa clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This expansion follows the recent enrollment of the first patient in the trial, announced on June 5, 2025, marking a significant milestone in the development of CMND-100. The study at Tel Aviv Sourasky Medical Centerwill be led by Dr. David Zeltser,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.